Electrocardiographic age acceleration was associated with significantly lower global cognitive scores in UK Biobank (β=-0.02) and Framingham (β=-0.04) cohorts.
Does ECG-derived biological age acceleration associate with lower cognitive performance in population-based cohorts?
ECG-derived biological age acceleration is significantly associated with poorer global cognitive performance, suggesting its potential as a scalable digital marker for cognitive decline risk.
Abstract Background Biological age derived from 12-lead electrocardiograms (ECGs) using deep learning has emerged as a promising marker of physiological aging. However, its relationship with cognitive performance remains poorly understood. Objective To investigate the association between ECG-derived aging and cognitive performance in two large population-based cohorts. Methods We analysed data from the UK Biobank (UKB) and the Framingham Heart Study (FHS). A deep learning model estimated ECG-based biological age (ECG-age) from ECG waveforms. We calculated the difference between ECG-age and chronological age (Δage), which was used to classify participants into aging groups: accelerated aging, normal aging, and decelerated aging. Cognitive performance was measured with standardized neuropsychological tests which were grouped into six cognitive domains and a global cognitive score. Multivariable linear regression models were used to examine the associations of Δage and aging groups with cognitive performance. Results Among 59,213 UKB participants (mean age 64.7 ± 7.8 years; 51.7% women) and 6,534 FHS participants (mean age 59.5 ± 14.5 years; 55.7% women), the mean absolute error between ECG-age and chronological age was 4.7 and 7.5 years, respectively. In both cohorts, higher Δage was associated with lower global cognitive performance (UKB: β = -0.02, 95% CI: -0.03, -0.02; FHS: β = -0.04, 95% CI: -0.06, -0.02) and poorer performance across multiple cognitive domains. Conclusions ECG-derived age acceleration is associated with poorer cognitive performance across two independent cohorts. ECG-based aging metrics may serve as scalable, low-cost digital markers to identify individuals at elevated risk for cognitive decline.
Ofosuhene et al. (2026) studied this question. Electrocardiographic age acceleration was associated with significantly lower global cognitive scores in UK Biobank (β=-0.02) and Framingham (β=-0.04) cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: